Quite a few patients affected by hidradenitis suppurativa/acne inversa suffer from disease manifestations long before targeted therapeutic measures are taken. There are various reasons for this. One approach to tackling the problem of diagnostic latency is to increase awareness and improve interdisciplinary networking. The evidence base and treatment options have expanded considerably in recent times. In the case of biologics, there are now several active substances to choose from and there have also been some innovations in antibiotics.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Findings from the TRACK-FA study
Neuroimaging biomarkers in Friedreich’s ataxia
- Doing sport without fear or risk
Doing sport without fear or risk
- Chronic inducible urticaria
What has stayed the same, what has changed?
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- Blastic plasmacytoid dendritic cell neoplasia
Rare malignancy from a dermatological perspective
- Glomerulonephritis: IgA nephropathy
Pathogenesis-based and nephroprotective therapeutic approaches
- Case report: Acute rheumatic fever
ARF with myocarditis and occlusion of the RCA
- Internal thoracoscopy